Pune-based drug discovery firm to start trial on anti- parasitic drug for Covid-19

CEO of Novalead, told ET that the firm will start phase 3 randomised trials to study whether the generic drug nitazoxanide brings down the viral load of a moderately ill Covid-19 patient, and the time taken for it. The secondary endpoint of the study will be to see if patients are able to get off oxygen support after administration of the drug.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/36skJUT
via IFTTT